In the present study, we found TUG1 overexpression reduced miR-221 that targeted PTEN, suggesting TUG1/miR-221/PTEN as a mode in regulating chemotherapy sensitivity NSCLC. Here, PTEN is linked to non-small cell lung carcinoma.